Zhang Minli, Eismin Ryan, Kenttämaa Hilkka, Xiong Hui, Wu Ye, Burdette Doug, Urbanek Rebecca
Drug Metabolism and Pharmacokinetics (M.Z.), and Medicinal Chemistry (Y.W., R.U.), AstraZeneca Pharmaceuticals, Boston, Massachusetts; Department of Chemistry, University of Arizona, Tucson, Arizona (R.E.); Department of Chemistry, Purdue University, West Lafayette, Indiana (H.K.); Avid Radiopharmaceuticals, Philadelphia, Pennsylvania (H.X.); Novartis Institutes for BioMedical Research, Boston, Massachusetts (D.B.)
Drug Metabolism and Pharmacokinetics (M.Z.), and Medicinal Chemistry (Y.W., R.U.), AstraZeneca Pharmaceuticals, Boston, Massachusetts; Department of Chemistry, University of Arizona, Tucson, Arizona (R.E.); Department of Chemistry, Purdue University, West Lafayette, Indiana (H.K.); Avid Radiopharmaceuticals, Philadelphia, Pennsylvania (H.X.); Novartis Institutes for BioMedical Research, Boston, Massachusetts (D.B.).
Drug Metab Dispos. 2015 Mar;43(3):358-66. doi: 10.1124/dmd.114.061978. Epub 2014 Dec 29.
2-Aminothiazolobenzazepine (2-ATBA), 7-[(1-methyl-1H-pyrazol-4-yl)methyl]-6,7,8,9-tetrahydro-5H-[1,3]thiazolo[4,5-h][3]benzazepin-2-amine, is a D2 partial agonist that has demonstrated antipsychotic effects in a rodent in vivo efficacy model. The metabolite profile showed that 2-ATBA is mainly metabolized by oxidation. However, identification of the oxidation site(s) in the 2-aminothiazole group presents a challenge for the traditional metabolite identification methods such as liquid chromatography/mass spectrometry and NMR due to the lack of unique tandem mass spectrometry fragmentation patterns for ions with the 2-aminothiazole group oxidized at different sites and the lack of stability for purification or reference standard synthesis. We describe the characterization of the oxidized heteroatoms of the 2-aminothiazole group via gas-phase ion-molecule reactions (GPIMR) in a modified linear quadrupole ion trap mass spectrometer. The GPIMR reagents used were dimethyl disulfide, tert-butyl peroxide, and tri(dimethylamino)borane. Each reagent was introduced into the ion trap through the helium line and was allowed to react with the protonated metabolites. The ionic ion-molecule reaction products and their fragmentation profiles were compared with the profiles of the ionic ion-molecule reaction products of protonated reference compounds that had specific heteroatom functionalities. The oxidized 2-aminothiazole metabolite of 2-ATBA showed a similar GPIMR profile to that of the reference compounds with a tertiary N-oxide functionality and distinct from the profiles of the reference compounds with N-aryl hydroxylamine, nitroso, or pyridine N-oxide functionalities. This study demonstrates the feasibility of fingerprinting the chemical nature of oxidized nitrogen functional groups via GPIMR profiling for metabolite structure elucidation.
2-氨基噻唑苯并氮杂䓬(2-ATBA),即7-[(1-甲基-1H-吡唑-4-基)甲基]-6,7,8,9-四氢-5H-[1,3]噻唑并[4,5-h][3]苯并氮杂䓬-2-胺,是一种D2部分激动剂,已在啮齿动物体内药效模型中显示出抗精神病作用。代谢物谱显示2-ATBA主要通过氧化代谢。然而,由于缺乏在不同位点氧化的2-氨基噻唑基团离子的独特串联质谱碎裂模式,以及缺乏用于纯化或参考标准合成的稳定性,对于传统的代谢物鉴定方法(如液相色谱/质谱和核磁共振)而言,鉴定2-氨基噻唑基团中的氧化位点是一项挑战。我们描述了在改良的线性四极杆离子阱质谱仪中通过气相离子-分子反应(GPIMR)对2-氨基噻唑基团氧化杂原子的表征。所使用的GPIMR试剂为二甲基二硫、叔丁基过氧化物和三(二甲氨基)硼烷。每种试剂通过氦气线路引入离子阱,并使其与质子化代谢物反应。将离子-分子反应产物及其碎裂谱与具有特定杂原子官能团的质子化参考化合物的离子-分子反应产物谱进行比较。2-ATBA的氧化2-氨基噻唑代谢物显示出与具有叔胺N-氧化物官能团的参考化合物相似的GPIMR谱,且与具有N-芳基羟胺、亚硝基或吡啶N-氧化物官能团的参考化合物谱不同。本研究证明了通过GPIMR谱图对氧化氮官能团的化学性质进行指纹识别以阐明代谢物结构的可行性。